Finance

Lists
COO:NASDAQ
Cooper Companies Inc
$56.77
-0.25%
(-0.14) 1D
$56.77
0.00% (0.00)
After hours
Closed: Oct 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COO...
Open
$56.37
High
$57.01
Low
$55.73
Mkt. cap
10.80B
Avg. vol.
4.32M
Volume
0.00
P/E ratio
19.37
52-wk high
$89.83
52-wk low
$51.01
EPS
$2.93
Beta
0.83
Shares outstanding
190.16M
No. of employees
15K
Open
$56.37
High
$57.01
Low
$55.73
Mkt. cap
10.80B
Avg. vol.
4.32M
Volume
0.00
P/E ratio
19.37
52-wk high
$89.83
52-wk low
$51.01
EPS
$2.93
Beta
0.83
Shares outstanding
190.16M
No. of employees
15K
News stories
From web sources and news partners
Profile
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical, which manufactures medical devices and fertility and genomic products for the women's healthcare market. Wikipedia
About Cooper Companies Inc
CEOAlbert G. White III
Employees15K
Founded1958
HeadquartersPleasanton, California, United States
SectorMedical device
Analyst ratings
Based on 13 analysts giving stock ratings to COO in the past 3 months
Buy
Buy
4
Hold
9
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for COO in the last 3 months.
Highest
Current $56.77
$75.00 (+32.11%)
Average
$65.27 (+14.97%)
Lowest
$58.00 (+2.17%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joanne Wuensch
Citi
Hold
Maintained
$60.00
+5.7%
10/02/2026
Jonathan Block
Stifel Nicolaus
Buy
Maintained
$70.00
+23.3%
10/01/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$75.00
+32.1%
09/11/2026
Young Li
Jefferies
Buy
Maintained
$70.00
+23.3%
09/10/2026
Steven Lichtman
William Blair
Hold
Downgraded
-
-
09/12/2026
Patrick Wood
UBS
Hold
Reiterated
$66.00
+16.3%
09/10/2026
Robbie Marcus
J.P. Morgan
Hold
Reiterated
$58.00
+2.2%
09/10/2026
David Saxon
Needham
Buy
Maintained
$73.00
+28.6%
09/10/2026
Travis Steed
Bank of America Securities
Hold
Downgraded
$65.00
+14.5%
09/10/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
$61.00
+7.5%
09/09/2026
Jason Bednar
Piper Sandler
Hold
Downgraded
$59.00
+3.9%
09/10/2026
Jeff Johnson
Robert W. Baird
Hold
Downgraded
$61.00
+7.5%
09/10/2026
Brett Fishbin
KeyBanc
Hold
Maintained
-
-
09/10/2026
Unknown Analyst
UBS
Hold
Initiated
$75.00
+32.1%
07/28/2026
David Roman
Goldman Sachs
Sell
Maintained
$61.00
+7.5%
05/27/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
$82.00
+44.4%
05/22/2026
Matt Miksic
Barclays
Buy
Reiterated
$103.00
+81.4%
03/24/2026
Issie Kirby
Rothschild & Co Redburn
Hold
Downgraded
$85.00
+49.7%
03/04/2026
Last report
Sep 9, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$1.15 / $1.12
+2.67%beat
Revenue / Est. (USD)
1.07B / 1.10B
-2.92%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
1.07B
1.02B
1.08B
1.07B
Cost of goods sold
414.30M
328.90M
346.10M
354.30M
Cost of revenue
414.30M
328.90M
346.10M
354.30M
Research and development expenses
41.40M
44.30M
42.50M
41.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
415.40M
390.20M
676.20M
401.30M
Operating expense
506.60M
482.40M
766.40M
489.90M
Total operating expenses
920.90M
811.30M
1.11B
844.20M
Operating income
144.20M
212.80M
-31.00M
222.00M
Other non operating income
-16.40M
3.10M
4.30M
4.50M
EBT including unusual items
116.80M
192.20M
-48.40M
201.80M
EBT excluding unusual items
101.10M
192.20M
-48.40M
201.80M
Income tax expense
32.20M
61.40M
29.50M
-231.00M
Effective tax rate
27.57%
31.95%
-60.95%
-114.47%
Other operating expenses
-
-
-
-
Net income
84.60M
130.80M
-77.90M
432.80M
Net profit margin
7.94%
12.77%
-7.20%
40.59%
Earnings per share
1.15
1.10
1.21
1.15
Interest and investment income
-
-
-
-
Interest expense
-24.40M
-22.40M
-20.90M
-21.50M
Net interest expenses
-24.40M
-22.40M
-20.90M
-21.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
242.60M
308.30M
64.40M
316.70M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps